Medical Grand Rounds

Thomas A. Waters, MD
Department of Emergency Medicine, Cleveland Clinic

Address: Thomas A. Waters, MD, Department of Emergency Medicine, E19, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195; [email protected]

Thomas A. Waters, MD
Department of Emergency Medicine, Cleveland Clinic

Address: Thomas A. Waters, MD, Department of Emergency Medicine, E19, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195; [email protected]

Thomas A. Waters, MD
Department of Emergency Medicine, Cleveland Clinic

Address: Thomas A. Waters, MD, Department of Emergency Medicine, E19, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195; [email protected]

Alejandro C. Arroliga, MD
Head, Section of Critical Care Medicine, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Address: Alejandro C. Arroliga, MD, Medical Intensive Care Unit, G62, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Alejandro C. Arroliga, MD
Head, Section of Critical Care Medicine, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Address: Alejandro C. Arroliga, MD, Medical Intensive Care Unit, G62, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Alejandro C. Arroliga, MD
Head, Section of Critical Care Medicine, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Address: Alejandro C. Arroliga, MD, Medical Intensive Care Unit, G62, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Franklin A. Michota, MD
Head, Section of Hospital and Preoperative Medicine, Department of General Internal Medicine, Cleveland Clinic

Address: Franklin A. Michota, MD, Section of Hospital and Preoperative Medicine, Department of General Internal Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Franklin A. Michota, MD
Head, Section of Hospital and Preoperative Medicine, Department of General Internal Medicine, Cleveland Clinic

Address: Franklin A. Michota, MD, Section of Hospital and Preoperative Medicine, Department of General Internal Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Franklin A. Michota, MD
Head, Section of Hospital and Preoperative Medicine, Department of General Internal Medicine, Cleveland Clinic

Address: Franklin A. Michota, MD, Section of Hospital and Preoperative Medicine, Department of General Internal Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Ann Marie Hake, MD
Department of Neurology, Indiana University School of Medicine

Address: Ann Marie Hake, MD, Department of Neurology, Indiana University School of Medicine, 541 Clinical Drive, Room 583, Indianapolis, IN 46202; [email protected]

Dr. Hake has indicated she is on the speakers bureau of the Novartis, Pfizer, Eisai, and Janssen corporations.

This paper discusses therapies that are not yet approved by the US Food and Drug Administration for the use under discussion.

Ann Marie Hake, MD
Department of Neurology, Indiana University School of Medicine

Address: Ann Marie Hake, MD, Department of Neurology, Indiana University School of Medicine, 541 Clinical Drive, Room 583, Indianapolis, IN 46202; [email protected]

Dr. Hake has indicated she is on the speakers bureau of the Novartis, Pfizer, Eisai, and Janssen corporations.

This paper discusses therapies that are not yet approved by the US Food and Drug Administration for the use under discussion.

Ann Marie Hake, MD
Department of Neurology, Indiana University School of Medicine

Address: Ann Marie Hake, MD, Department of Neurology, Indiana University School of Medicine, 541 Clinical Drive, Room 583, Indianapolis, IN 46202; [email protected]

Dr. Hake has indicated she is on the speakers bureau of the Novartis, Pfizer, Eisai, and Janssen corporations.

This paper discusses therapies that are not yet approved by the US Food and Drug Administration for the use under discussion.

David L. Longworth, MD
Chairman, Department of Infectious Diseases, Cleveland Clinic

Address: David L. Longworth, MD, Department of Infectious Diseases, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

David L. Longworth, MD
Chairman, Department of Infectious Diseases, Cleveland Clinic

Address: David L. Longworth, MD, Department of Infectious Diseases, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

David L. Longworth, MD
Chairman, Department of Infectious Diseases, Cleveland Clinic

Address: David L. Longworth, MD, Department of Infectious Diseases, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Raed A. Dweik, MD
Staff Physician, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Address: Raed A. Dweik, MD, Department of Pulmonary and Critical Care Medicine, A90,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland OH 44195; [email protected]

Dr. Dweik discusses therapies that are not yet labeled (FDA-approved) for the use under discussion or products that are still investigational.

Raed A. Dweik, MD
Staff Physician, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Address: Raed A. Dweik, MD, Department of Pulmonary and Critical Care Medicine, A90,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland OH 44195; [email protected]

Dr. Dweik discusses therapies that are not yet labeled (FDA-approved) for the use under discussion or products that are still investigational.

Raed A. Dweik, MD
Staff Physician, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Address: Raed A. Dweik, MD, Department of Pulmonary and Critical Care Medicine, A90,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland OH 44195; [email protected]

Dr. Dweik discusses therapies that are not yet labeled (FDA-approved) for the use under discussion or products that are still investigational.

Brian F. Mandell, MD, PhD
Department of Rheumatic and Immunologic Diseases, Cleveland Clinic; Senior Associate Program Director, Internal Medicine Residency Program; Deputy Editor, Cleveland Clinic Journal of Medicine

Address: Brian F. Mandell, MD, PhD, Cleveland Clinic Journal of Medicine, NA32,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Mandell has indicated that he has received grant or research support from the Novartis, Smith-Kline, Centocor, Searle, and Merck corporations, and that this article discusses therapies that are not yet approved by the Food and Drug Administration for the use under discussion or that are still under investigation.

Brian F. Mandell, MD, PhD
Department of Rheumatic and Immunologic Diseases, Cleveland Clinic; Senior Associate Program Director, Internal Medicine Residency Program; Deputy Editor, Cleveland Clinic Journal of Medicine

Address: Brian F. Mandell, MD, PhD, Cleveland Clinic Journal of Medicine, NA32,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Mandell has indicated that he has received grant or research support from the Novartis, Smith-Kline, Centocor, Searle, and Merck corporations, and that this article discusses therapies that are not yet approved by the Food and Drug Administration for the use under discussion or that are still under investigation.

Brian F. Mandell, MD, PhD
Department of Rheumatic and Immunologic Diseases, Cleveland Clinic; Senior Associate Program Director, Internal Medicine Residency Program; Deputy Editor, Cleveland Clinic Journal of Medicine

Address: Brian F. Mandell, MD, PhD, Cleveland Clinic Journal of Medicine, NA32,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Mandell has indicated that he has received grant or research support from the Novartis, Smith-Kline, Centocor, Searle, and Merck corporations, and that this article discusses therapies that are not yet approved by the Food and Drug Administration for the use under discussion or that are still under investigation.

Gary W. Falk, MD
Director, Center for Swallowing and Esophageal Disorders, Department of Gastroenterology, Cleveland Clinic

Address: Gary W. Falk, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Falk has indicated that he has received grant or research support from the Astra-Zeneca and US Endoscopy corporations, and serves as a consultant for the Astra-Zeneca and Merck corporations.

Gary W. Falk, MD
Director, Center for Swallowing and Esophageal Disorders, Department of Gastroenterology, Cleveland Clinic

Address: Gary W. Falk, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Falk has indicated that he has received grant or research support from the Astra-Zeneca and US Endoscopy corporations, and serves as a consultant for the Astra-Zeneca and Merck corporations.

Gary W. Falk, MD
Director, Center for Swallowing and Esophageal Disorders, Department of Gastroenterology, Cleveland Clinic

Address: Gary W. Falk, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Falk has indicated that he has received grant or research support from the Astra-Zeneca and US Endoscopy corporations, and serves as a consultant for the Astra-Zeneca and Merck corporations.

Victor L. Yu, MD
Professor of Medicine, University of Pittsburgh; Chief, Infectious Disease Section, VA Medical Center, Pittsburgh, Pennsylvania

Address: Victor L. Yu, MD, Infectious Diseases Section, VA Medical Center, University Drive C, Pittsburgh, PA 15240

Dr. Yu has indicated that he has received grant or research support from the Pfizer, Abbott, and Ortho-McNeil corporations.

Victor L. Yu, MD
Professor of Medicine, University of Pittsburgh; Chief, Infectious Disease Section, VA Medical Center, Pittsburgh, Pennsylvania

Address: Victor L. Yu, MD, Infectious Diseases Section, VA Medical Center, University Drive C, Pittsburgh, PA 15240

Dr. Yu has indicated that he has received grant or research support from the Pfizer, Abbott, and Ortho-McNeil corporations.

Victor L. Yu, MD
Professor of Medicine, University of Pittsburgh; Chief, Infectious Disease Section, VA Medical Center, Pittsburgh, Pennsylvania

Address: Victor L. Yu, MD, Infectious Diseases Section, VA Medical Center, University Drive C, Pittsburgh, PA 15240

Dr. Yu has indicated that he has received grant or research support from the Pfizer, Abbott, and Ortho-McNeil corporations.